Should I buy CVS Health (CVS) stock or is it too late?
⭐ The most reliable of them, either direction: Morgan Stanley — 69% of its targets hit on this sector (825 calls tested). It aims for $111 (+20 %), call made on June 5, 2026, maturing on June 5, 2027 (84 d ago).
Firm-by-firm track record on CVS Health
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Truist Securities | 80 % | +25.0 % | 10 | $118 +27% |
| Barclays | 74 % | +16.1 % | 19 | $108 +16% |
| UBS | 69 % | +9.8 % | 13 | $126 +36% |
| Morgan Stanley | 57 % | +8.8 % | 23 | $111 +19% |
| JP Morgan | 58 % | +6.8 % | 12 | $118 +27% |
| Piper Sandler | 50 % | +6.8 % | 6 | $99 +7% |
| Mizuho | 60 % | +3.5 % | 10 | $115 +24% |
| Cantor Fitzgerald | 36 % | +1.5 % | 11 | $110 +18% |
✅ Reasons to believe
- 100% of analysts rate it a buy (Buy consensus, 16 ratings) — a sign of market conviction.
- Median price target $112, i.e. +21% from the current price ($93).
- The most reliable firm on CVS, Wells Fargo (100% hit rate, 4 scored calls), targets $123 (call made on July 13, 2026, maturing on July 13, 2027) (+32%) in its most recent call, and $102 (call made on November 13, 2025, maturing on November 13, 2026) (+10%) in the one coming due soonest.
- 9 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (2.5% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- A near-unanimous consensus leaves little room for positive surprise — a lot of optimism is already baked in.
The analyst consensus on CVS
Median target $112 (+21%) · 16 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in CVS Health now?
We won't decide for you. The facts: 100% of analysts rate it a buy, median target $112 (+21%), and Wells Fargo (most reliable on CVS, 100%) targets $123. Weigh that against valuation (P/E ~25). This is not personalized advice.
Is it too late to invest in CVS Health?
Not according to analysts: the median target ($112) is still +21% above the current price ($93) (most reliable on CVS: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is CVS Health still worth investing in?
It depends on the gap between the price ($93) and its estimated value: analysts target $112 on median (+21%), with 100% buys (most reliable on CVS: Wells Fargo, 100%). Cross-check with their real reliability on CVS and the cautions above. Information, not advice.
What's the main risk in buying CVS?
A 12-month target is not a guaranteed path: the price can fall in the meantime.
→ Go deeper: the full CVS Health profile (consensus, analyst reliability, price target, performance).